The cost-effectiveness of aspirin for chemoprevention of colorectal cancer

被引：1

作者：

Provenzale, D ^{[1
]}

机构：

[1] Duke Univ, Sch Med, Durham, NC USA

来源：

关键词：

D O I：

10.1053/gast.2002.30618

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：230 / 233

页数：4

共 10 条

[1] Bloom B S, 1988, Am J Med, V84, P20, DOI 10.1016/0002-9343(88)90250-1
[2] Gold MR, 1996, COST EFFECTIVENESS H
[3] An overview of the 4 randomized trials of aspirin therapy in the primary prevention of vascular disease
Hebert, PR
Hennekens, CH
[J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (20) : 3123 - 3127
[4] Provenzale D, 1999, AM J GASTROENTEROL, V94, P2043
[5] Rahme E, 2000, ARTHRITIS RHEUM-US, V43, P917, DOI 10.1002/1529-0131(200004)43:4<917::AID-ANR25>3.0.CO
[6] 2-F
[7] Excess costs from gastrointestinal disease associated with nonsteroidal anti-inflammatory drugs
Smalley, WE
Griffin, MR
Fought, RL
Ray, WA
[J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 1996, 11 (08) : 461 - 469
[8] Cost-effectiveness of colonoscopy in screening for colorectal cancer
Sonnenberg, A
Delcò, F
Inadomi, JM
[J]. ANNALS OF INTERNAL MEDICINE, 2000, 133 (08) : 573 - 584
[9] Chemoprevention of colorectal cancer by aspirin: A cost-effectiveness analysis
Suleiman, S
Rex, DK
Sonnenberg, A
[J]. GASTROENTEROLOGY, 2002, 122 (01) : 78 - 84
[10] Wagner JL., 1996, Prevention and early detection of colorectal cancer, P321